SMSNA
US$ 25.89
glp 1 and perimenopause GLP-1 Agonists in Perimenopause: Unique Risks Potential Opportunities Understanding GLP-1 Benefits for Perimenopause
Description
Moreover, Zinman et al
F., Nauck M
Special Note
Study characteristics The included studies were published between 2016 and 2025, with sample sizes ranging from 3,183 to 17,604 participants
Role of GLP-1 in Congenital Hyperinsulinism Congenital hyperinsulinism is the most common cause of persistent hypoglycemia in neonates, infants, and children
GLP-1 is constantly secreted from the intestine at low basal levels in the fasted and interprandial state, and circulating GLP-1 levels increase 2- to 3-fold after nutrient ingestion
